InvestSMART

MedAdvisor Limited (ASX: MDR) - Announcements

Current share price for MDR : $0.022 0.002 (10%)+

ASX company news and announcements for MedAdvisor Limited (MDR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All MedAdvisor Limited (MDR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than MedAdvisor Limited (MDR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for MedAdvisor Limited (MDR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Appendix 3B 18 Apr 2016 12:53PM $0.029 $0.022 fallen by 24.14%
- Change of Director's Interest Notice - Read 8 Apr 2016 12:38PM $0.030 $0.022 fallen by 26.67%
- MedAdvisor Investor Presentation 1 Apr 2016 9:21AM $0.031 $0.022 fallen by 29.03%
- International pharma expert joins MedAdvisor Advisory Board 23 Mar 2016 12:16PM $0.034 $0.022 fallen by 35.29%
- MedAdvisor & Arrow to launch strategic partnership 21 Mar 2016 10:09AM $0.033 $0.022 fallen by 33.33%
- MedAdvisor launches 1st phase of highly anticipated GP Link 18 Mar 2016 10:17AM $0.035 $0.022 fallen by 37.14%
- MDR appoints renowned industry figures to Advisory Board 16 Mar 2016 2:52PM $0.035 $0.022 fallen by 37.14%
- Appendix 4D - MedAdvisor Half Year Financial Results Dec-15 29 Feb 2016 10:05AM $0.035 $0.022 fallen by 37.14%
- QUARTERLY ACTIVITIES REPORT and APPENDIX 4C 29 Jan 2016 9:56AM $0.039 $0.022 fallen by 43.59%
- Painaustralia launches MedAdvisor Patient Pain Education Prg 22 Jan 2016 1:45PM $0.037 $0.022 fallen by 40.54%
- MDR reaches 1 million prescription milestone 22 Jan 2016 9:35AM $0.035 $0.022 fallen by 37.14%
- Initial Director's Interest Notice - Hook 21 Jan 2016 9:35AM $0.037 $0.022 fallen by 40.54%
- MedAdvisor strengthens Board of Directors with new appointee 19 Jan 2016 4:07PM $0.032 $0.022 fallen by 31.25%
- Signs partnership agreement with Epilepsy Queensland Inc. 8 Jan 2016 10:19AM $0.035 $0.022 fallen by 37.14%
- Vesting of CEO Performance Rights & Expiry of Listed Options 4 Jan 2016 12:04PM $0.037 $0.022 fallen by 40.54%
- Options Subject to Escrow 30 Dec 2015 1:26PM $0.039 $0.022 fallen by 43.59%
- MedAdvisor appoints ex-GSK Sales and Marketing Specialist 18 Dec 2015 11:20AM $0.039 $0.022 fallen by 43.59%
- Results of Annual General Meeting 18 Dec 2015 11:11AM $0.039 $0.022 fallen by 43.59%
- Appendix 3B 10 Dec 2015 6:38PM $0.039 $0.022 fallen by 43.59%
- Option Expiry 1 Dec 2015 5:45PM $0.052 $0.022 fallen by 57.69%
- Change of Registered Address 1 Dec 2015 5:40PM $0.052 $0.022 fallen by 57.69%
- MedAdvisor Investor Presentation 1 Dec 2015 12:09PM $0.049 $0.022 fallen by 55.10%
- Medication Adherence Platform, MedAdvisor, lists on the ASX 1 Dec 2015 10:01AM $0.045 $0.022 fallen by 51.11%
- Statement of Confirmations to ASX 30 Nov 2015 10:50AM n/a $0.022 n/a
- Terms and Conditions of Convertible Securities 30 Nov 2015 10:48AM n/a $0.022 n/a

726 - 750 of 761 results

Page 30 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.